Evidence map›Paper›PMID 39161536›Full record

ReviewJournal of blood medicine2024

A Systematic Review of the Epidemiology and Disease Burden of Congenital and Immune-Mediated Thrombotic Thrombocytopenic Purpura.

Ping Du, Tiffany Cristarella, Camille Goyer, Yola Moride

Abstract readReview
In one paragraph

Review in Journal of blood medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. A rapid ADAMTS13 activity assay using a portable readout device.Blood vessels, thrombosis & hemostasis · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Tailored treatment of acute immune-mediated thrombotic thrombocytopenic purpura.Hematology. American Society of Hematology. Education Program · 2025
    Review
  11. All-Cause and Exacerbation-Related Readmissions in Thrombotic Microangiopathy Requiring Plasmapheresis: A Population-Based Cohort StudyTurkish journal of haematology : official journal of Turkish Society of Haematology · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ping DuGlobal Evidence and Outcomes, Takeda Development Center Americas, Inc., Cambridge, MA, USA.ORCID 0000-0003-1329-790X
Tiffany CristarellaYolaRX Consultants Inc., Montreal, QC, Canada.ORCID 0000-0002-9334-6611
Camille GoyerYolaRX Consultants Inc., Montreal, QC, Canada.ORCID 0000-0002-9361-8840
Yola MorideYolaRX Consultants Inc., Montreal, QC, Canada.ORCID 0000-0002-8753-2274

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Congenital (cTTP) and immune-mediated (iTTP) thrombotic thrombocytopenic purpura are serious and rare clotting disorders resulting from a deficiency in the ADAMTS13 enzyme. A systematic review was conducted using the Ovid

Indexed as

ADAMTS13burden of illnessdisease managementepidemiologypatient-reported outcomesthrombotic thrombocytopenic purpura

Identifiers

PMID39161536
PMCPMC11330749

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.